ALL vs KROS · P/E 4.9, rev $18.60B vs rev $32.0K
The Allstate Corporation (ALL) versus Keros Therapeutics Inc (KROS) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. KROS currently screens at market cap $208.8M.
Not investment advice. Open the ALL and KROS stock pages for the full models.
Not investment advice.